Published in Transl Stroke Res on March 07, 2012
Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab (2012) 1.39
Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol (2012) 1.14
Sulfonylurea receptor 1 expression in human cerebral infarcts. J Neuropathol Exp Neurol (2013) 1.08
Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab (2012) 1.01
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke (2013) 0.97
Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) (2013) 0.96
Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl Stroke Res (2013) 0.96
Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci (2012) 0.96
The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity. Brain Sci (2013) 0.88
Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci (2015) 0.88
Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocrit Care (2014) 0.86
Intravenous infusion of magnesium chloride improves epicenter blood flow during the acute stage of contusive spinal cord injury in rats. J Neurotrauma (2013) 0.83
Effect of glibenclamide on the prevention of secondary brain injury following ischemic stroke in humans. Neurosurg Focus (2014) 0.83
Glibenclamide in cerebral ischemia and stroke. Neurocrit Care (2014) 0.82
MRI evidence that glibenclamide reduces acute lesion expansion in a rat model of spinal cord injury. Spinal Cord (2013) 0.81
Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts. J Neuropathol Exp Neurol (2015) 0.80
Heterogeneity of aquaporin-4 localization and expression after focal cerebral ischemia underlies differences in white versus grey matter swelling. Acta Neuropathol Commun (2015) 0.80
The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia. J Neuroinflammation (2016) 0.77
Glibenclamide for the treatment of ischemic and hemorrhagic stroke. Int J Mol Sci (2015) 0.76
Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats. J Am Heart Assoc (2016) 0.76
SUR1-Associated Mechanisms Are Not Involved in Ischemic Optic Neuropathy 1 Day Post-Injury. PLoS One (2016) 0.75
A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury. J Neurotrauma (2015) 0.75
Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 6.79
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol (1992) 3.49
Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med (2006) 2.57
Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle. Circ Res (2003) 2.35
Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke (2008) 2.10
Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost (1981) 1.98
Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest (2007) 1.84
Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2008) 1.77
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation (2003) 1.77
Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke (2008) 1.64
Clot retrieval for stroke should be restricted to clinical trials: no. Stroke (2009) 1.63
Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke (2010) 1.52
Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke (2005) 1.32
Does arterial recanalization improve outcome in carotid territory stroke? Stroke (1995) 1.24
Comparison of silicon-coated nylon suture to plain nylon suture in the rat middle cerebral artery occlusion model. J Neurosci Methods (2006) 1.17
Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats? J Cereb Blood Flow Metab (2010) 1.07
Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model. Neurol Res (2003) 1.07
Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8. J Cereb Blood Flow Metab (2011) 1.04
Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem (2007) 1.03
Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique. Exp Neurol (2003) 0.99
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke (2004) 0.97
Use of telemetry blood pressure transmitters to measure intracranial pressure (ICP) in freely moving rats. Curr Neurovasc Res (2009) 0.93
The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia. Int Rev Neurobiol (2007) 0.91
Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a rat model of transient focal cerebral ischemia. Chin Med J (Engl) (2008) 0.85
Intracranial pressure changes following middle cerebral artery occlusion in rats. Res Exp Med (Berl) (1991) 0.84
Influence of different fixation procedures on the quantification of infarction and oedema in a rat model of stroke. Neuropathol Appl Neurobiol (2000) 0.83
Recovery from ischemic brain injury in the rat following a 10 h delayed injection with MLN519. Pharmacol Biochem Behav (2005) 0.79
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol (2007) 3.33
Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med (2006) 2.57
Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic Acids Res (2004) 2.54
Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle. Circ Res (2003) 2.35
Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke (2007) 2.10
Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study. Bipolar Disord (2013) 2.07
Long-term outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the Spetzler-Martin classification. J Neurosurg (2012) 2.03
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry (2008) 1.89
Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest (2007) 1.84
Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2008) 1.77
Maturation of TonEBP expression in developing rat kidney. Am J Physiol Renal Physiol (2004) 1.70
Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke (2008) 1.64
Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci (2003) 1.55
Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke (2010) 1.52
De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med (2009) 1.42
Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg Focus (2007) 1.41
Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab (2012) 1.39
Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma (2008) 1.30
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2009) 1.28
Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med (2010) 1.28
Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma (2009) 1.27
Relaxation in a completely integrable many-body quantum system: an ab initio study of the dynamics of the highly excited states of 1D lattice hard-core bosons. Phys Rev Lett (2007) 1.25
Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) (2009) 1.24
Novel treatment targets for cerebral edema. Neurotherapeutics (2012) 1.20
Progesterone in traumatic brain injury. N Engl J Med (2015) 1.20
The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem (2012) 1.18
Hemorrhagic progression of a contusion after traumatic brain injury: a review. J Neurotrauma (2011) 1.17
Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol (2012) 1.14
Silencing of TonEBP/NFAT5 transcriptional activator by RNA interference. J Am Soc Nephrol (2003) 1.12
Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol (2011) 1.11
Towards a Meso-Scale SMA-Actuated MRI-Compatible Neurosurgical Robot. IEEE Trans Robot (2011) 1.09
Rodent model of direct cranial blast injury. J Neurotrauma (2011) 1.08
Drugs acting on SUR1 to treat CNS ischemia and trauma. Curr Opin Pharmacol (2007) 1.08
Sulfonylurea receptor 1 expression in human cerebral infarcts. J Neuropathol Exp Neurol (2013) 1.08
Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol (2010) 1.06
Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center. Arthritis Rheum (2005) 1.06
Comparison of experimental lung injury from acute renal failure with injury due to sepsis. Respiration (2006) 1.05
Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8. J Cereb Blood Flow Metab (2011) 1.04
rTMS for suppressing neuropathic pain: a meta-analysis. J Pain (2009) 1.03
Non-selective cation channels, transient receptor potential channels and ischemic stroke. Biochim Biophys Acta (2007) 1.03
Transient receptor potential melastatin 4 and cell death. Pflugers Arch (2012) 1.02
Novel model of frontal impact closed head injury in the rat. J Neurotrauma (2009) 1.01
Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage. Transl Stroke Res (2012) 1.00
Dimerization is required for phosphorylation and DNA binding of TonEBP/NFAT5. Biochem Biophys Res Commun (2002) 1.00
Transforming growth factor-beta 1 regulates Kir2.3 inward rectifier K+ channels via phospholipase C and protein kinase C-delta in reactive astrocytes from adult rat brain. J Biol Chem (2001) 1.00
Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. J Neurosurg (2010) 0.99
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke (2013) 0.97
Complex deformities of the cervical spine. Neurosurg Clin N Am (2007) 0.97
EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients. Am J Physiol Cell Physiol (2006) 0.96
Regulation of TonEBP transcriptional activator in MDCK cells following changes in ambient tonicity. Am J Physiol Cell Physiol (2002) 0.96
Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) (2013) 0.96
Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle. J Physiol (2005) 0.96
Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci (2012) 0.96
Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Transl Stroke Res (2013) 0.96
Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease. Stroke (2006) 0.96
3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J (2003) 0.95
Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am J Physiol Cell Physiol (2002) 0.95
Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology. World J Gastroenterol (2013) 0.92
Comparative study of decompressive craniectomy after mass lesion evacuation in severe head injury. Neurosurgery (2009) 0.92
Fetal and ovarian radiation dose in patients undergoing gamma knife radiosurgery. Surg Neurol (2002) 0.91
Mislocalization of eNOS and upregulation of cerebral vascular Ca2+ channel activity in angiotensin-hypertension. Hypertension (2003) 0.91
Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function. Mol Pharmacol (2009) 0.90
Mechanisms of astrocyte-mediated cerebral edema. Neurochem Res (2014) 0.90
Craniectomy for malignant cerebral infarction: prevalence and outcomes in US hospitals. PLoS One (2011) 0.89
The protective effect of glibenclamide in a model of hemorrhagic encephalopathy of prematurity. Brain Sci (2013) 0.88